China vs Mus: Cases started on MDR-TB treatment
China
13,984
in 2024
Mus
0
in 2024
China rank
3rd
Mus rank
2nd
Cases started on MDR-TB treatment over time
- China
- Mus
How they compare
China currently reports 13,984 against 0 in Mus, a difference of 13,984.
Across all 16 years both countries report, China has been ahead every year.
China ranks 3rd and Mus ranks 2nd of 193 countries.
China has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | China | Mus | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 458 | 1 | 457 | China |
| 2010s | 4,884 | 1.5 | 4,883 | China |
| 2020s | 12,695 | 0.8 | 12,694 | China |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher cases started on mdr-tb treatment, China or Mus?
- China, at 13,984 against 0 in Mus as of 2024.
- What is the difference in cases started on mdr-tb treatment between China and Mus?
- 13,984, with China ahead.
- How many years of comparable data are there for China and Mus?
- 16 years are reported by both, from 2009 to 2024.
- How do China and Mus rank globally for cases started on mdr-tb treatment?
- China ranks 3rd and Mus ranks 2nd of 193 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Cases started on MDR-TB treatment. Statizoid refreshes it automatically from the source and publishes the full history for both places.